Brånemark Clinic, Public Dental Health Care Service, Gothenburg, Region of Västra Götaland, Sweden.
Department of Prosthetic Dentistry/Dental Material Science, The Sahlgrenska Academy at Göteborg University, Gothenburg, Sweden.
Clin Implant Dent Relat Res. 2020 Oct;22(5):567-573. doi: 10.1111/cid.12931. Epub 2020 Aug 11.
This study aimed to report implant failures before and after peri-implantitis surgery (P-IS) and to compare the pattern of implant failures with in untreated at-risk patients during the same period.
A total of 5628 untreated at-risk patients (7240 jaws) and 207 consecutively patients treated with P-IS (212 jaws) were included in two groups. Implants were placed and followed-up between 1986 and 2018. Cumulative survival rates (CSR) for patients treated with P-IS after 2003 were calculated before and after P-IS and compared with those for nontreated patients.
The overall 15-year CSR was 91.2% (CI 95%; 90.5%-91.9%) and 68.5%, (CI 95%, 62.1%-75.5%) for untreated patients at risk and P-IS patients, respectively (P < .05). The 10-year CSR (baseline 1 year after implant surgery) was 97.2% (CI 95%, 95.2%-100%) for treated patients before P-IS which was comparable with that for untreated patients: 95.4% (CI 95%, 94.8%-97.7%). The corresponding 10-year CSR for P-IS patients after surgery was significantly lower (71.6%: CI 95%, 63.1%-81.3% (P < .05)).
CSR for patients/jaws without implant failures was comparable between untreated and treated P-IS patients before, but lower for P-IS patients after P-IS (P < .05). A negative effect of P-IS on implant survival after treatment cannot be disregarded.
本研究旨在报告种植体周围炎(peri-implantitis surgery,P-IS)治疗前后的种植体失败情况,并比较同期未经治疗的高危患者中种植体失败的模式。
共纳入 5628 例未经治疗的高危患者(7240 个颌骨)和 207 例连续接受 P-IS 治疗的患者(212 个颌骨),两组患者分别于 1986 年至 2018 年期间植入种植体并进行随访。2003 年后,对接受 P-IS 治疗的患者,计算 P-IS 治疗前后的累积生存率(cumulative survival rate,CSR),并与未治疗患者进行比较。
总体 15 年 CSR 分别为 91.2%(CI 95%;90.5%-91.9%)和 68.5%(CI 95%;62.1%-75.5%),分别为高危未治疗患者和 P-IS 治疗患者(P<.05)。治疗患者在 P-IS 治疗前的 10 年 CSR(基线为植入手术后 1 年)为 97.2%(CI 95%;95.2%-100%),与未治疗患者相似:95.4%(CI 95%;94.8%-97.7%)。而手术后 P-IS 患者的相应 10 年 CSR 显著较低(71.6%:CI 95%;63.1%-81.3%(P<.05))。
在 P-IS 治疗前后,无种植体失败的患者/颌骨的 CSR 在未经治疗和接受治疗的 P-IS 患者之间具有可比性,但在 P-IS 治疗后,P-IS 患者的 CSR 较低(P<.05)。P-IS 对治疗后种植体存活的负面影响不容忽视。